Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein S26 pseudogene 8 (*RPS26P8*) is a processed pseudogene found in the human genome[1]. Pseudogenes such as RPS26P8 are derived from functional genes like *RPS26* through gene duplication and subsequent loss of protein-coding capability; they do not produce functional protein products[1][5][7]. This pseudogene is not known to be involved in any cellular process, disease, or drug interactions, and is not a therapeutic target. Multiple processed pseudogenes for ribosomal proteins exist in the human genome, but these typically serve as evolutionary remnants rather than active biological components[1][5]. If you are seeking therapeutic or biological information, refer to the parent gene **ribosomal protein S26** (*RPS26*) instead, which encodes a component of the 40S ribosomal subunit and is implicated in protein synthesis and Diamond-Blackfan anemia[3][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S26 pseudogene 8 (RPS26P8).